112 related articles for article (PubMed ID: 38110163)
1. Design, development, and evaluation of CDK-4/6 inhibitor loaded 4-carboxy phenyl boronic acid conjugated pH-sensitive chitosan lecithin nanoparticles in the management of breast cancer.
Pooja YS; Rajana N; Yadav R; Naraharisetti LT; Godugu C; Mehra NK
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128821. PubMed ID: 38110163
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
3. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
4. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
[TBL] [Abstract][Full Text] [Related]
6. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
[TBL] [Abstract][Full Text] [Related]
7. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
8. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
10. Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior
Abosabaa SA; Arafa MG; ElMeshad AN
Drug Deliv; 2021 Dec; 28(1):2160-2176. PubMed ID: 34623203
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea-loaded Fe
Chaghervand MM; Torbati MB; Shaabanzadeh M; Ahmadi A; Tafvizi F
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):51-63. PubMed ID: 34661718
[TBL] [Abstract][Full Text] [Related]
12. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
13. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
14. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS
Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330
[TBL] [Abstract][Full Text] [Related]
15. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
16. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin.
Jardim KV; Siqueira JLN; Báo SN; Sousa MH; Parize AL
Carbohydr Polym; 2020 Jan; 227():115351. PubMed ID: 31590861
[TBL] [Abstract][Full Text] [Related]
17. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
20. Anticancer efficacy of 6-thioguanine loaded chitosan nanoparticles with or without curcumin.
Rajashekaraiah R; Kumar PR; Prakash N; Rao GS; Devi VR; Metta M; Narayanaswamy HD; Swamy MN; Satyanarayan K; Rao S; Rathnamma D; Sahadev A; Sunilchandra U; Santhosh CR; Dhanalakshmi H; Kumar SN; Ruban SW; Kalmath GP; Gomes AR; Kumar KRA; Govindappa PK
Int J Biol Macromol; 2020 Apr; 148():704-714. PubMed ID: 31954127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
